Institutional members access full text with Ovid®

Share this article on:

Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab

Le Garff, Gwenaëlle; Samri, Assia; Lambert-Niclot, Sidonie; Even, Sophie; Lavolé, Armelle; Cadranel, Jacques; Spano, Jean-Philippe; Autran, Brigitte; Marcelin, Anne-Geneviève; Guihot, Amélie

doi: 10.1097/QAD.0000000000001429
Correspondence

aService de Pneumologie, CH Yves Le Foll, Saint-Brieuc

bINSERM, U 1135, CIMI

cSorbonne Universités, UPMC Univ Paris 06

dINSERM, UMRS 1136, Institut Pierre Louis d’épidémiologie et de Santé Publique

eAP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie

fService de Pneumologie, AP-HP Hôpital Tenon

gGRC 04 Theranoscan UPMC Univ Paris 06, Sorbonne Universités

hDepartment of Medical Oncology, Groupe hospitalier Pitié-Salpêtrière-Charles Foix, AP-HP

iDépartement d’Immunologie, APHP, Hôpital Pitié Salpêtrière, Paris, France.

*Gwenaëlle Le Garff and Assia Samri contributed equally to this article.

Correspondence to Amélie Guihot, MD, PhD, Département d’immunologie, Hôpital Pitié-Salpêtrière, Paris, France. Tel: +33 1 42 17 79 30; fax: +33 1 42 17 74 90; e-mail: amelie.guihot@aphp.fr

Received 5 January, 2017

Revised 17 January, 2017

Accepted 30 January, 2017

Copyright © 2017 Wolters Kluwer Health, Inc.